Smart nanomedicines for overcoming biological barriers and improving delivery efficiency

The nanomedicine that integrates nanotechnology with chemistry and medicine has emerged as a new scientific area and received tremendous attention. In recent years, the delivery of nanomedicines to the targeted region in vivo has been the focus of intense research. However, a series of biological barriers in blood circulation/extravasation, tissue accumulation/penetration, cellular internalization/efflux, and lysosome escape encountered by nanomedicines after systemic administration greatly limit their delivery efficiency and theranostic efficacy. Remarkably, some new delivery mechanisms are discovered and explored, such as active transcytosis and live cell migration, which requires us to revisit the strategies for overcoming biological barriers and enhancing disease theranostics. Therefore, the development of novel strategies (e.g., stimuli-responsive charge conversion and size transformation, biomimetic and living cell systems, as well as exogenous assistance technologies) to address the delivery dilemma for precise and efficient targeted delivery of nanomedicines is one of the hot topics of nanobiotechnology and biomedicine. Moreover, these strategies can also offer interesting pharmacological, physical, and biological solutions for promoted disease theranostics and clinical translation.This special issue will address advanced design and new developments of smart nanomedicines for overcoming biological barriers and improving delivery efficiency.

Guest editors:

Prof. Andrij Pich - DWI Leibniz-Institute for Interactive Materials, RWTH Aachen University, Aachen, Germany.

Prof. Xiangyang Shi - Donghua University, Shanghai, China. Prof. Yong Hu - Tongji University, Shanghai City, China.

Dr. Xin Li - RWTH Aachen University, Aachen, Germany.

Manuscript submission information:

Submission Deadline: 31st March 2024.

The journal’s submission platform (Editorial Manager®) is now available for receiving submissions to this Special Issue. Please refer to the Guide for Authors to prepare your manuscript, and select the article type of “VSI:Smart nanomedicines” when submitting your manuscript online. Both the Guide for Authors and the submission portal could be found on the Journal Homepage here: https://www.journals.elsevier.com/journal-of-pharmaceutical-analysis

Keywords:

Smart and bioactive nanoparticles; Emerging nanomedicines; Multidrug resistance reversal nanosystems; Immunomodulatory nanosystems; Biomimetic nanocarriers; Cell-mediated nanomedicine delivery and release;Endogenous/exogenous-responsive behaviors;

Why publish in this Special Issue?

• Special Issue articles are published together on ScienceDirect, making it incredibly easy for other researchers to discover your work.

• Special content articles are downloaded on ScienceDirect twice as often within the first 24 months than articles published in regular issues.

• Special content articles attract 20% more citations in the first 24 months than articles published in regular issues.

• All articles in this special issue will be reviewed by no fewer than two independent experts to ensure the quality, originality and novelty of the work published.

Learn more about the benefits of publishing in a special issue.

Interested in becoming a guest editor? Discover the benefits of guest editing a special issue and the valuable contribution that you can make to your field.